Clinical Trial Update: A+C in Metastatic Lung Adenocarcinoma Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on a combination therapy for metastatic lung adenocarcinoma. The current status is listed as UNKNOWN in the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Lung Adenocarcinoma Metastatic | Phase 2 | Status: UNKNOWN